Biotech

All Articles

ArsenalBio increases $325M, rotates away from previous lead possession

.Toolbox Biosciences is carrying on up. The tissue treatment business has actually added on $325 mil...

Lilly- supported weight reduction biotech files IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' marijuana usage drug flunks period 2b, steering Indivior to review $100M choice

.Aelis Farma's hopes of securing an easy, favorable choice on a $100 thousand possibility repayment ...

ProKidney halts stage 3 trial not needed for tissue therapy approval

.ProKidney has actually stopped some of a pair of stage 3 tests for its tissue therapy for renal ill...

Vaxcyte rises on 'magnificent' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what experts named "stunning" period 1/2 records for its 31-valent pneumococcal va...

Recursion's brain ailment trial presents insufficient proof of efficiency

.Recursion has discovered with an early exam of its tech-enabled method to drug revelation, stating ...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Phone it a case of excellent chemistry: Acepodia, a biotech based on Nobel Prize-winning science, i...

Praxis epilepsy medication lessens confiscations in stage 2 hearing

.Praxis Accuracy Medicines has actually racked up an additional midphase gain in epilepsy this year,...

Three officers resign as Dyne articles mixed information for DMD applicant

.After getting away from a medical grip many years back, Dyne Therapeutics has exposed new period 1/...

Arrowhead fires off phase 3 records in unusual metabolic condition before market clash with Ionis

.Arrowhead Pharmaceuticals has shown its give ahead of a possible showdown with Ionis, publishing pe...